Jennifer Markarian

Emergence of advanced manufacturing technology to ensure quality of biopharmaceutical drugs combined with efforts to identify a regulatory pathway indicate that a distributed manufacturing model is within reach.

Process automation technologies aid modernization and enable closed systems.

Manufacturers face the challenge of meeting growing demand for personalized biopharmaceuticals.

Automation enables intensification of downstream processes.

Automation and digitalization work together in the digital plant.

Precompetitive consortiums seek solutions to industry-wide challenges.

BioPharm International spoke with Colleen Floreck, vice president, Global Marketing and Strategy, Catalent Cell and Gene Therapy about the specific requirements and challenges for expanding production of viral vectors.

Flexible and efficient methods are needed for biopharmaceutical manufacturing.

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.

Innovations aid efficient processing.